At 211 MAb BC8-B10

N/A

Report date: 2025/11/25 15:56:50

Base Information

Drug NameAt 211 MAb BC8-B10
Drug Alias NameAstatine At 211 MAb BC8-B10At 211 Anti-CD45 Monoclonal Antibody BC8-B10Astatine 211-Labeled Anti-CD45 Monoclonal Antibody BC8-B10astatine At 211 anti-CD45 monoclonal antibody BC8-B10
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyRadiation-emitting products > Radioactive therapeutic agent +[5] 
Mechanisms of ActionAnti-CD45
TargetsLeukocyte common antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFred Hutchinson Cancer Research Center
China Registration ClassN/A

Develop Information

Active CompaniesFred Hutchinson Cancer Research Center
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A